Antibacterial drug discovery and structure-based design

Drug Discovery Today
John J Barker

Abstract

Bacterial resistance continues to develop and pose a significant threat, both in hospitals and, more recently, in the community. A focus on other therapeutic areas by the larger pharmaceutical companies has left a shortfall in the pipeline of novel antibacterials. Recently, many new structures have been studied by structure-genomics initiatives, delivering a wealth of targets to consider. Using the tools of structure-based design, antibacterial discovery must exploit these targets to accelerate the process of drug discovery.

References

May 23, 1998·Science·N S DuesberyG F Vande Woude
Aug 26, 1998·The Journal of Biological Chemistry·P T Rajagopalan, D Pei
Mar 19, 1999·The Journal of Infectious Diseases·H F Chambers
Sep 28, 1999·Cell·R A Mooney, R Landick
Aug 30, 2000·Biochemical Society Transactions·N Vazquez-LaslopA A Neyfakh
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·M PutmanW N Konings
Jun 8, 2001·Annual Review of Biochemistry·J J Champoux
Apr 17, 2002·Cell·Klaus P Hoeflich, Mitsuhiko Ikura
May 10, 2002·Nature·Dmitry G VassylyevShigeyuki Yokoyama
May 22, 2002·Applied Microbiology and Biotechnology·R J HeathC O Rock
Oct 11, 2002·Nature·Satoshi MurakamiAkihito Yamaguchi
Nov 19, 2002·FEBS Letters·Paolo AscenziCesare Montecucco
Nov 30, 2002·Trends in Pharmacological Sciences·Milton T Stubbs
Dec 21, 2002·Molecular Microbiology·Ahmed El ZoeibyRoger C Levesque
Jan 16, 2003·Trends in Microbiology·Kenneth S McKeeganAdrian R Walmsley
Feb 7, 2003·Current Drug Targets. Infectious Disorders·Marion S Helfand, Robert A Bonomo
Jun 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Douglas A WhittingtonDavid W Christianson
Sep 19, 2003·The Biochemical Journal·M Ines Borges-WalmsleyAdrian R Walmsley
Oct 3, 2003·Chemistry & Biology·Amy C Anderson
Nov 25, 2003·FEBS Letters·Geoffrey Chang
Nov 25, 2003·Journal of Viral Hepatitis·R M Smith, G Y Wu
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Gerardo D FranciscoTarek S Mansour
Dec 20, 2003·Organic & Biomolecular Chemistry·Alan G SutherlandKaren L Wheless
Jan 14, 2004·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Feb 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Che Ma, Geoffrey Chang
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yuequan ShenWei-Jen Tang
Feb 26, 2004·Bioorganic & Medicinal Chemistry·Nicolas FoloppeRob Howes
Mar 10, 2004·Bioorganic & Medicinal Chemistry Letters·Lee D JenningsAlan G Sutherland
Mar 10, 2004·Bioorganic & Medicinal Chemistry Letters·Valentina MolteniYun He

❮ Previous
Next ❯

Citations

May 24, 2011·Journal of Computer-aided Molecular Design·Wan F LauJames E Mills
Jun 1, 2008·Indian Journal of Microbiology·Kishore R Sakharkar, Vincent T K Chow
Mar 14, 2012·Analytical Chemistry·Kavya Swaminathan, Kevin M Downard
Nov 1, 1996·Seminars in Nephrology·A Fogo, V Kon
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver
Nov 16, 2010·Future Microbiology·Heike Brötz-Oesterhelt, Peter Sass
Jun 29, 2011·Future Microbiology·Claudia Sala, Ruben C Hartkoorn
Sep 2, 2011·Future Medicinal Chemistry·Takushi KanekoKhisimuzi Mdluli
Aug 8, 2009·Expert Opinion on Therapeutic Targets·Sonia Kapoor, Dulal Panda
Aug 1, 2008·Expert Review of Respiratory Medicine·Haruaki TomiokaToshiaki Shimizu
Feb 1, 2010·Expert Opinion on Drug Discovery·J Richard Miller, Grover L Waldrop
May 3, 2011·European Journal of Medicinal Chemistry·Liane Saíz-UrraMatheus Froeyen
Jun 2, 2009·Current Opinion in Microbiology·Thomas R Ioerger, James C Sacchettini
Aug 2, 2006·Angewandte Chemie·Franz von NussbaumDieter Häbich
Jul 28, 2011·Medicinal Research Reviews·Frederick Harris, Lynne Pierpoint
Oct 24, 2006·Drug Discovery Today·Nicolas FoloppeFareed Aboul-Ela
Aug 26, 2006·Current Opinion in Microbiology·Paul Stothard, David S Wishart
Oct 20, 2006·Carbohydrate Research·Iwona KudybaAndrea Vasella
May 6, 2015·Drug Discovery Today·Rajalakshmi Rajasekaran, Yi-Ping Phoebe Chen
Aug 1, 2007·Expert Opinion on Drug Discovery·Tod P HollerLakshmi Narasimhan
Dec 3, 2014·Protein Expression and Purification·Htin Lin AungBrian C Monk
Aug 23, 2011·Bioorganic & Medicinal Chemistry·Gaston H M VondenhoffArthur Van Aerschot
Oct 5, 2011·European Journal of Medicinal Chemistry·Gaston H M Vondenhoff, Arthur Van Aerschot
Oct 13, 2011·ACS Medicinal Chemistry Letters·Martin J McPhillieColin W G Fishwick
Dec 16, 2016·Expert Opinion on Therapeutic Patents·Juan SunHai-Liang Zhu
Feb 23, 2012·Journal of Physics. Condensed Matter : an Institute of Physics Journal·Matteo CeccarelliPaolo Ruggerone
May 1, 2017·Archives of Pharmacal Research·Shahzaib AhamadMd Imtaiyaz Hassan
Dec 21, 2010·Journal of Proteome Research·Artem CherkasovNeil E Reiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Antimicrobial Agents
Robert C Moellering
Nature Reviews. Microbiology
Christopher Walsh
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
K Bush
© 2022 Meta ULC. All rights reserved